1. Home
  2. NPCE vs ENTA Comparison

NPCE vs ENTA Comparison

Compare NPCE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.48

Market Cap

432.3M

Sector

Health Care

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.06

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
ENTA
Founded
1997
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.3M
374.6M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
NPCE
ENTA
Price
$15.48
$14.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$18.33
$20.40
AVG Volume (30 Days)
165.9K
110.5K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
29.93
EPS
N/A
N/A
Revenue
$99,986,000.00
$102,814,000.00
Revenue This Year
$0.90
$7.76
Revenue Next Year
$24.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.13
16.48
52 Week Low
$7.56
$4.96
52 Week High
$18.97
$17.15

Technical Indicators

Market Signals
Indicator
NPCE
ENTA
Relative Strength Index (RSI) 62.07 57.22
Support Level $15.25 $13.39
Resistance Level $15.71 $15.52
Average True Range (ATR) 0.67 0.76
MACD 0.22 0.20
Stochastic Oscillator 91.26 74.84

Price Performance

Historical Comparison
NPCE
ENTA

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: